Kumar Ajay, Mazumdar Anirban, Bhattacharjee A K, Gupta Arvind, Dasgupta Arundhati, Sinha Binayak, Saboo Banshi, Selvan Chitra, Goyal Ghanshyam, Balaji Jaganmohan, Seshadri Krishna G, Gangopadhyay Kalyan K, Kumar G Vijay, Chawla Manoj, Sikdar Mohua, Deka Nilakshi, Singh N K, Chawla Purvi, Jetwani Pratap, Kovil Rajiv, Ghosal Samit, Ray Subir, Chatterjee Sudip, Chandrasekharan Sruti, Das Sambit, Ghosh Subhajyoti, Patange Sonali, Reddy Sanjay, Surekha T
Private Clinic, Patna, India.
KPC Medical College, Kolkata, India.
BMC Nephrol. 2025 May 16;26(1):245. doi: 10.1186/s12882-025-04164-6.
Type 2 diabetes (T2DM) is the leading cause of chronic kidney disease (CKD) worldwide. Identifying clinical and laboratory associations with chronic kidney disease (CKD) in type 2 diabetes (T2DM) can help physicians target modifiable risk factors. In light of limited data from India, the CITE (CKD in Indian T2DM Evaluation) study was conducted.
The multicenter, cross-sectional CITE study included 3,325 patients from 28 centres across India over a three-month period. CKD was defined as a persistent decline in kidney function (eGFR < 60 ml/min/1.73 m² for ≥ 3 months) or an elevated urine albumin-to-creatinine ratio (UACR) in at least two samples. Descriptive statistics summarised patient characteristics, while logistic regression analyses identified significant risk factors for CKD.
The prevalence of CKD in T2DM was 32%, with a median patient age of 59.9 years and 60.72% having a T2DM duration > 10 years. Reduced eGFR (< 60 ml/min/1.73 m²) was associated with older age (OR: 2.47, 95% CI 2.11-2.88, P < 0.001), longer T2DM duration (OR: 2.28, 95% CI 1.77-2.93, P < 0.001), higher HbA1c (OR: 1.039, 95% CI 1.001-1.079, P = 0.046), and elevated SBP (OR: 1.005, 95% CI 1.002-1.009, P = 0.003). Macroalbuminuria (UACR > 300 mg/g) was linked to non-vegetarian diet (OR: 1.95, 95% CI: 1.59-2.40, P < 0.001) and tobacco use (OR: 1.42, 95% CI: 1.17-1.73, P < 0.001). CKD increased comorbidity odds.
The CITE study highlights the prevalence of CKD (32%) in Indian patients with T2DM and identifies clinical and laboratory factors associated with CKD, including age ≥ 60 years, T2DM duration, SBP, HbA1c, tobacco use, non-vegetarian diet, and comorbidities. Longitudinal studies are needed to confirm these associations and evaluate causality.
2型糖尿病(T2DM)是全球慢性肾脏病(CKD)的主要病因。确定2型糖尿病(T2DM)中与慢性肾脏病(CKD)相关的临床和实验室因素有助于医生针对可改变的风险因素。鉴于来自印度的数据有限,开展了CITE(印度T2DM患者CKD评估)研究。
这项多中心横断面CITE研究在三个月期间纳入了来自印度28个中心的3325例患者。CKD的定义为肾功能持续下降(估算肾小球滤过率[eGFR]<60ml/min/1.73m²且持续≥3个月)或至少两份样本中的尿白蛋白肌酐比值(UACR)升高。描述性统计总结了患者特征,而逻辑回归分析确定了CKD的显著风险因素。
T2DM患者中CKD的患病率为32%,患者中位年龄为59.9岁,60.72%的患者T2DM病程>10年。eGFR降低(<60ml/min/1.73m²)与年龄较大(比值比[OR]:2.47,95%置信区间[CI]2.11 - 2.88,P<0.001)、T2DM病程较长(OR:2.28,95%CI 1.77 - 2.93,P<0.001)、糖化血红蛋白(HbA1c)较高(OR:1.039,95%CI 1.001 - 1.079,P = 0.046)以及收缩压(SBP)升高(OR:1.005,95%CI 1.002 - 1.009,P = 0.003)相关。大量白蛋白尿(UACR>300mg/g)与非素食饮食(OR:1.95,95%CI:1.59 - 2.40,P<0.001)和吸烟(OR:1.42,95%CI:1.17 - 1.73,P<0.001)有关。CKD增加了合并症发生几率。
CITE研究突出了印度T2DM患者中CKD的患病率(32%),并确定了与CKD相关的临床和实验室因素,包括年龄≥60岁、T2DM病程、SBP、HbA1c、吸烟、非素食饮食和合并症。需要进行纵向研究来证实这些关联并评估因果关系。